HEADER DEOXYRIBONUCLEIC ACID 17-DEC-01 1KML TITLE COMPUTER MODEL OF A COVALENT COMPLEX BETWEEN TITLE 2 D(GTGGCGGCGGCC) AND THREE MOLECULES OF ANTITUMOR DRUG TITLE 3 ECTEINASCIDIN 743 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 5'-D(*GP*TP*GP*GP*CP*GP*GP*CP*GP*GP*CP*C)-3'; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 OTHER_DETAILS: THREE COVALENT ADDUCTS BETWEEN ET743 AND COMPND 6 DNA; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: 5'-D(*GP*GP*CP*CP*GP*CP*CP*GP*CP*CP*AP*C)-3'; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 MOL_ID: 2; SOURCE 4 SYNTHETIC: YES KEYWDS ANTICANCER, DNA, ECTEINASCIDIN, DEOXYRIBONUCLEIC ACID EXPDTA THEORETICAL MODEL AUTHOR E.MARCO,R.GARCIA-NIETO,J.MENDIETA,I.MANZANARES,C.CUEVAS, AUTHOR 2 F.GAGO REVDAT 2 15-FEB-02 1KML 1 JRNL REVDAT 1 21-DEC-01 1KML 0 JRNL AUTH E.MARCO,R.GARCIA-NIETO,J.MENDIETA,I.MANZANARES, JRNL AUTH 2 C.CUEVAS,F.GAGO JRNL TITL A 3.(ET743)-DNA COMPLEX THAT BOTH RESEMBLES AN JRNL TITL 2 RNA-DNA HYBRID AND MIMICKS ZINC FINGER-INDUCED DNA JRNL TITL 3 STRUCTURAL DISTORTIONS. JRNL REF J.MED.CHEM. V. 45 871 2002 JRNL REFN ASTM JMCMAR US ISSN 0022-2623 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1KML COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-DEC-2001. REMARK 100 THE RCSB ID CODE IS RCSB015114. REMARK 101 REMARK 101 RESIDUE G A 3 HAS ECT BONDED TO N2. REMARK 101 RESIDUE G A 6 HAS ECT BONDED TO N2. REMARK 101 RESIDUE G A 9 HAS ECT BONDED TO N2. REMARK 105 REMARK 105 THE PROTEIN DATA BANK HAS ADOPTED THE SACCHARIDE CHEMISTS REMARK 105 NOMENCLATURE FOR ATOMS OF THE DEOXYRIBOSE/RIBOSE MOIETY REMARK 105 RATHER THAN THAT OF THE NUCLEOSIDE CHEMISTS. THE RING REMARK 105 OXYGEN ATOM IS LABELLED O4* INSTEAD OF O1*. REMARK 220 REMARK 220 EXPERIMENTAL DETAILS REMARK 220 EXPERIMENT TYPE : THEORETICAL MODELLING REMARK 220 REMARK 220 REMARK: NULL REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1EZ5 RELATED DB: PDB REMARK 900 COMPUTER MODEL OF A COVALENT COMPLEX BETWEEN D(TAAAGCTTA) REMARK 900 AND ANTITUMOR DRUG ECTEINASCIDIN 743 REMARK 900 RELATED ID: 1EZH RELATED DB: PDB REMARK 900 COMPUTER MODEL OF A COVALENT COMPLEX BETWEEN D(TAACGGTTA) REMARK 900 AND ANTITUMOR DRUG ECTEINASCIDIN 743 SEQRES 1 A 12 G T G G C G G C G G C C SEQRES 1 B 12 G G C C G C C G C C A C HET ECT 1 96 HET ECT 2 96 HET ECT 3 96 HETNAM ECT ECTEINASCIDIN 743 FORMUL 3 ECT 3(C39 H43 N3 O11 S) LINK N2 G A 3 C40 ECT 1 LINK N2 G A 6 C40 ECT 2 LINK N2 G A 9 C40 ECT 3 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MASTER 41 0 3 0 0 0 0 6 0 0 0 2 END